[1]沈霖 马陈 帅波△ 杨艳萍 徐晓娟 李成刚 夏雪 吕林.加味青娥丸对非创伤性股骨头坏死患者脂联素信号转导通路相关受体和饥饿素表达的影响[J].中国中医骨伤科杂志,2016,24(08):5-10.
　SHEN Lin MA Chen SHUAI Bo YANG Yanping XU Xiaojuan LI Chenggang XIA Xue L Lin.Effects of Modified Qing'e Pill on the Expression of Adiponectin,Adiponectin Receptors and Ghrelin in Patients with Nontraumatic Osteonecrosis of the Femoral Head[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2016,24(08):5-10.
点击复制

加味青娥丸对非创伤性股骨头坏死患者脂联素信号转导通路相关受体和饥饿素表达的影响
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第24卷
期数:
2016年08期
页码:
5-10
栏目:
临床研究
出版日期:
2016-08-01

文章信息/Info

Title:
Effects of Modified Qing'e Pill on the Expression of Adiponectin,Adiponectin Receptors and Ghrelin in Patients with Nontraumatic Osteonecrosis of the Femoral Head
文章编号:
1005-0205(2016)08-0005-06
作者:
沈霖1 马陈1 帅波1△ 杨艳萍1 徐晓娟1 李成刚1 夏雪1 吕林1
1.华中科技大学同济医学院附属协和医院(武汉,430022)
Author(s):
SHEN Lin1 MA Chen1 SHUAI Bo1△ YANG Yanping1 XU Xiaojuan1 LI Chenggang1 XIA Xue1 LÜ Lin1
1.Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China.
关键词:
股骨头坏死;  青娥丸;  脂联素;  脂联素受体;  饥饿素
Keywords:
femoral head necrosis;  modified qing'e pill;  adiponectin;  adiponectin receptors;  ghrelin
分类号:
R274.39
文献标志码:
A
摘要:
目的:观察加味青娥丸对非创伤性股骨头坏死患者脂联素信号转导通路相关受体和饥饿素表达的影响,以探讨加味青娥丸治疗非创伤性股骨头坏死的机制。 方法:招募临床诊断为非创伤性股骨头坏死患者,随机分为治疗组及对照组,治疗组给予加味青娥丸及补钙治疗,对照组给予模拟剂及补钙治疗,疗程均为6个月,两组患者适当限制运动及负重。另招募60例健康体检者作为健康组。抽取两组患者治疗前后及健康组静脉血,采用ELISA法检测患者治疗前后血浆脂联素和饥饿素的水平; RT-PCR方法检测患者治疗前后脂联素、脂联素受体1和受体2 mRNA的表达。同步观察患者治疗前后股骨骨密度、髋部X线片及髋关节功能评分(Harris评分),比较两组患者上述指标的差异。结果:治疗后6个月,治疗组患者血浆脂联素、饥饿素及脂联素受体1和受体2 mRNA的表达水平显著高于治疗前; 治疗组髋关节Harris评分高于对照组; 两组患者髋部X片影像学观察及骨密度无明显差异。结论:中药加味青娥丸可能通过调节非创伤性股骨头坏死患者脂联素信号通路相关受体mRNA及饥饿素水平,改善脂质代谢状态而对股骨头坏死疾病起到一定的治疗作用。
Abstract:
Objective:To observe the regulation of modified Qing'e pill on the expression level of adiponectin,adiponectin receptors and ghrelin in patients with nontraumatic osteonecrosis of the femoral head(ONFH),for providing an experimental base of its clinical application.Methods:All 60 patients with nontraumatic ONFH were randomly divided into the treatment group and the control group.The treatment group was treated by modified Qing'e pill while the control group was treated with simulated pill.All patients were also given Caltrate D oral.They were treated for six months.Another 60 cases of healthy people accepted heath examination were as healthy group.Serum adiponectin and ghrelin were measured by enzyme-linked immunosorbent assay(ELISA)method,and the expression of adiponectin,adiponectin receptor 1 and adiponectin receptor 2 mRNA were detected by fluorescent real-time quantitative polymerase chain reaction(RT-PCR)in patients with ONFH before and after the treatment and healthy control group.While X-ray examination of the hip,bone mineral density(BMD)of the femoral head and Harris score were measured in patients with ONFH before and after treatment.Results:The levels of serum adiponectin and ghrelin in patients with ONFH were significantly different from healthy controls.The expression of adiponectin and AdipoR1/2 in patients with ONFH were significantly lower than that in healthy controls.After six months treatment,levels of serum adiponectin and ghrelin,the expression of adiponectin,AdipoR1/2 in treatment group were significantly higher than baseline.Harris score in the treatment group were significantly higher than that in the control group.BMD of the hip and X-ray examination of the hip were no significant difference between treatment group and control group after treatment.Conclusion:Modified Qing'e pill may play a protective role against nontraumatic ONFH by regulating the adiponectin signaling pathway and ghrelin.

参考文献/References:

[1]Kerachian MA,Seguin C,Harvey EJ.Glucocorticoids in osteonecrosis of the femoral head:a new understanding of the mechanisms of action[J].The Journal of Steroid Biochemistry and Molecular Biology,2009,114(3-5):121-128.
[2] Kaneshiro Y,Takaoka K.Hepatic CYP3A activity in association with development of osteonecrosis of the femoral head[J].Clinical Calcium,2007,17(6):902-909.
[3] Kim H,Cho C,Cho Y,et al.Significant associations of PAI-1 genetic polymorphisms with osteonecrosis of the femoral head[J].BMC Musculoskeletal Disorders,2011,12(1):160-164.
[4] Shuai B,Shen L,Yang YP,et al.Low plasma adiponectin as a potential biomarker for osteonecrosis of the femoral head[J].J Rheumatol,2010,37(10):2151-2155.
[5] Li Chenggang,Shen Lin,Yang Yanping,et al.Plasma ghrelin and von willebrand factor levels in patients with non-traumatic osteonecrosis of the femoral head[J].Hip Int,2015,25(1):76-81.
[6] 帅波,沈霖,杨艳萍,等.早期非创伤性股骨头坏死患者脂联素及相关因子与骨髓水肿及疼痛分级的相关性研究[J].中国疼痛医学杂志,2011,17(11):643-647.
[7] Shuai B,Yang YP,Shen L,et al.Effect of Qing'e pill plus salvia on non-traumatic osteonecrosis of the femoral head of Idiopathic type in earlier stage:a case report of a twelve-month of period[J].Chin Med,2014,5(2):113-117.
[8] 杨艳萍,沈霖,刘诗荣,等.补肾活血方对实验性兔股骨头缺血性坏死骨密度的影响[J].中国中医骨伤科杂志,2004,12(1):5-7.
[9] 周丕琪,沈霖,杨艳萍,等.补肾活血中药对兔股骨头缺血性坏死骨密度和生物力学影响的研究[J].中国康复医学杂志,2006,21(12):1139-1143.
[10] 沈霖,杜靖远,杨家玉,等.青娥丸加味对大鼠卵巢切除诱导的试验性骨质疏松症的影响[J].中医研究,1994,7(2):19-21.
[11] Balsan GA,Vieira JL,Oliveira AM,et al.Relationship between adiponectin,obesity and insulin resistance[J].Rev Assoc Med Bras,2015,61(1):72-80.
[12] Esfahani M,Movahedian A,Baranchi M,et al.Adiponectin:an adipokine with protective features against metabolic syndrome[J].Iran J Basic Med Sci,2015,18(5):430-442.
[13] Zhao L,Fu Z,Wu J,et al.Globular adiponectin ameliorates metabolic insulin resistance via AMPK-mediated restoration of microvascular insulin responses[J].J Physiol,2015,593(17):4067-4079.
[14] Xu Y,Zhang C,Wang N,et al.Adiponectin inhibits lymphotoxin-beta receptor-mediated NF-kappaB signaling in human umbilical vein endothelial cells[J].Biochemi Biophys Res Commun,2011,404(4):1060-1064.
[15] Register TC,Divers J,Bowden DW,et al.Relationships between serum adiponectin and bone density,adiposity and calcified atherosclerotic plaque in the African American-Diabetes heart study[J].J Clin Endocrinol Metab,2013,98(5):1916-1922.
[16] Kajimura D,Lee HW,Riley KJ,et al.Adiponectin regulates bone mass via opposite central and peripheral mechanisms through FoxO1[J].Cell Metab,2013,17(6):901-915.
[17] Mrak E,Casati L,Pagani F,et al.Ghrelin increases beta-catenin level through protein kinase a activation and regulates OPG expression in rat primary osteoblasts[J].Int J Endocrinol,2015,2015:547473.
[18] Võsoberg K,Tillmann V,Tamm AL, et al.Adipocytokine and ghrelin levels in relation to bone mineral density in preubertal rhythmic gymnasts entering puberty:a 3-year follow-up study[J].Eur J Appl Physiol,2016,116(4):831-839.
[19] Napoli N,Pedone C,Pozzilli P,et al.Effect of ghrelin on bone mass density:the inchianti study[J].Bone,2011,49(2):257-263.
[20] Gómez-Mont Landerreche JG,Gil-Orbezo F,Morales-Dominguez H,et al.Nontraumatic causes of bilateral avascular necrosis of the femoral head:link between hepatitis C and pegylated interferon[J].Acta Ortop Mex,2015,29(3):172-175.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金项目(81273907,81403257)
△.通信作者 E-mail:bobo3137@126.com
更新日期/Last Update: 2016-08-02